HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹5.13 Cr | ₹4.74 Cr | ₹4.10 Cr | ₹3.51 Cr | ₹3.04 Cr |
What is the latest Long Term Provisions ratio of HALEOS LABS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹5.13 Cr |
| Mar2024 | ₹4.74 Cr |
| Mar2023 | ₹4.10 Cr |
| Mar2022 | ₹3.51 Cr |
| Mar2021 | ₹3.04 Cr |
How is Long Term Provisions of HALEOS LABS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.13 Cr | 8.27 | |
| Mar2024 | ₹4.74 Cr | 15.58 | |
| Mar2023 | ₹4.10 Cr | 16.93 | |
| Mar2022 | ₹3.51 Cr | 15.55 | |
| Mar2021 | ₹3.04 Cr | - | |
Compare Long Term Provisions of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹499.0 Cr | 22.3% | -1.6% | 29.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 22.3% |
-1.6% |
29.8% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses